454219-01-3Relevant academic research and scientific papers
Beta3 agonists and uses thereof
-
, (2008/06/13)
Sulfamide compounds having formula (I) are described as well as their use in the treatment of diseases dependent on the signaling pathways associated with β-adrenergic receptors, such as obesity, diabetes, hypertension, gastrointestinal hypo- or hyper-mot
Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof
-
Page 20, (2010/01/31)
Sulfamide compounds having formula (I) are described as well as their use in the treatment of diseases dependent on the signaling pathways associated with β-adrenergic receptors, such as obesity, diabetes, hypertension, gastrointestinal hypo- or hyper-motility and cardiovascular diseases.
